search
Back to results

Efficacy and Safety of Using Noninvasive Ventilation Associated With Recruitment Maneuver in Cardiac Surgery.

Primary Purpose

Hypoxia

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
recruitment group (RG)
control group (CG)
Sponsored by
Mieko Cláudia Miura
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypoxia focused on measuring noninvasive ventilation, myocardial revascularization, pulmonary atelectasis, hypoxia, positive end-expiratory pressure, coronary artery bypass grafting, extracorporeal circulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged 18 years or over;
  • Hypoxemia defined by ratio PaO2/FiO2 < 300 in extubation;
  • Glasgow Coma Scale > 11 after extubation;
  • Chest radiograph with radiological atelectasis score ≥ 2 The radiological score of atelectasis: 0, without atelectasis; 1, line of atelectasis or discrete infiltration; 2, partial atelectasis; 3, lobar atelectasis and 4, bilateral lobar atelectasis.

Exclusion Criteria:

  • Use of vasoconstrictor drugs in increasing doses throughout the last two hours (norepinephrine increasing ≥ 0.5 mcg / kg / min, or increase of dopamine ≥ 5mcg/kg/min) or arterial pressure <65 mmHg;
  • Presence of a tracheostomy;
  • Global initiative for Obstructive Lung Disease (GOLD) classification > 2 and pulmonary fibrosis;
  • Contraindication to use of NIV;
  • Refuse of RM by the surgeon / doctor in charge.

Sites / Locations

  • Hospital do Coracao

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

recruitment group (RG)

control group (CG)

Arm Description

After extubation the patient who was randomized to the Recruitment Group (RG) used noninvasive ventilation (NIV) associated with recruitment maneuver with PEEP 15 cm H2O and afterwards 20 cm H2O remaining 2 minutes in each, then being maintained in NIV until 30 minutes with pressure support for a tidal volume of 6 mL/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen (FiO2) for a peripheral oxygen saturation (SpO2) ≥ 95%.

After extubation the patient who was randomized to the Control Group (CG) used noninvasive ventilation (NIV) for 30 minutes with pressure support for a tidal volume of 6 ml/Kg, PEEP 8 cm H2O, FiO2 for a SpO2 ≥ 95%.

Outcomes

Primary Outcome Measures

Oxygenation improvement
Arterial blood gas sample was collected in pressure support ventilation on the day of extubation and on the following days, it was collected after 2 minutes in room air, daily until ICU discharge. Oxygenation improvement was the difference between partial oxygen pressure at the day of ICU discharge and the day of extubation.

Secondary Outcome Measures

Atelectasis score improvement
Radiological Atelectasis Score was attributed by a physician not related to the study, according to chest radiograph, with the following scores: 0, without atelectasis; 1, line of atelectasis or discrete infiltration; 2, partial atelectasis; 3, lobar atelectasis and 4, bilateral lobar atelectasis.
Barotrauma
Occurrence of pneumothorax, pneumomediastinum, subcutaneous emphysema or pneumoperitoneum during or after noninvasive ventilation associated or not to recruitment maneuver.
Arrhythmia
Occurrence of cardiac arrhythmia during or after noninvasive ventilation associated or not to recruitment maneuver.
Hemodynamic instability
Occurrence of heart rate > 120 beats per minute or < 20 points from baseline value, systolic blood pressure < 90 or > 160 mmHg during or after noninvasive ventilation associated or not to recruitment maneuver.
Extubation failure rate
The failure of extubation was defined as the requirement of reintubation of the extubated patients within a 48hour period.
ICU lenght of stay
Number of days that the patient stayed at the ICU.
Mortality intrahospital
Occurrence of death during hospital stay.

Full Information

First Posted
September 14, 2016
Last Updated
January 10, 2018
Sponsor
Mieko Cláudia Miura
Collaborators
Hospital do Coracao
search

1. Study Identification

Unique Protocol Identification Number
NCT02913391
Brief Title
Efficacy and Safety of Using Noninvasive Ventilation Associated With Recruitment Maneuver in Cardiac Surgery.
Official Title
Efficacy and Safety of Using Noninvasive Ventilation Associated With Recruitment Maneuver in the Postoperative Period of Coronary Artery Bypass Grafting: a Controlled Randomized Clinical Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
April 2016 (Actual)
Primary Completion Date
April 2017 (Actual)
Study Completion Date
September 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Mieko Cláudia Miura
Collaborators
Hospital do Coracao

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Cardiac surgery can evolve with complications in the postoperative period, atelectasis and hypoxemia are the major pulmonary dysfunctions. They can lead to a prolonged length of stay in the hospital, increasing morbidity and mortality. In order to prevent or reduce such complications noninvasive ventilation (NIV) has been used in the postoperative period in a prophylactic and therapeutic way. The use of positive end-expiratory pressure (PEEP) is widely practice in intensive care unit (ICU), being used in patients under mechanical ventilation, NIV and exercises with intermittent positive pressure. The recruitment maneuver (RM) consists of sustained increase of pressure in the airway using PEEP in individuals with hypoxemia, in order to minimize the deleterious effects from alveolar collapse, providing a more homogeneous ventilation of the pulmonary parenchyma increasing the pulmonary area available for gas exchange and, consequently, arterial oxygenation. In recent years the increase in the application of PEEP in cardiac patients under has shown great benefits and the use of NIV to improve oxygenation by the reversal of atelectasis is already used and recommended in hospital routine. Despite NIV being used in great proportion, the relevant literature is poor in showing studies with NIV associated with RM in postoperative period of cardiac surgery. Therefore, the aims of this study are to evaluate if the use of NIV associated with RM improves oxygenation and if it can be safely applied in coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) postoperative patients.
Detailed Description
This work was a controlled and randomized clinical trial, where patients were analyzed in postoperative period of CABG with CPB. The protocol study was approved by Ethics Committee of the Faculty of Medicine, University os São Paulo and the Ethics Committee of the Hospital do Coração. Written informed consent was obtained from the patients or their surrogates at the thime of their enrollment. Patients, doctors and nursing team were blinded to which group the patient was allocated, only the physiotherapy team, responsible for applying NIV therapy in the study, was aware of group allocation after randomization. All the patients were ventilated in Servo I (MAQUET Critical Care AB™, Sweden) and used the FitLife total face mask (Philips Respironics™, USA). Randomization was performed using a computer-based software. Patients eligible to the study were randomly assigned to the Control Group (CG) or Recruitment Group (RG). CG used NIV for 30 minutes with pressure support for a tidal volume of 6 mL/Kg, PEEP 8 cm H2O, fractional inspired oxygen (FiO2) for a peripheral oxygen saturation (SpO2) ≥ 95%. RG used NIV with RM with PEEP 15 cm H2O and afterwards 20 cm H2O remaining 2 minutes in each level, then being maintained in NIV for 30 minutes with pressure support for a tidal volume of 6 mL/Kg, PEEP 8 cm H2O, FiO2 for a SpO2 ≥ 95%. Patients were monitored during the whole NIV session.The RM would be interrupted and medical staff would be called to check the patient if any clinical instability occurred during or after RM, such as barotrauma, respiratory instability, hemodynamic instability and arrhythmia. Medical staff would take the required measures for the safety of the patient. Safety criteria for Interruption of RM: respiratory rate > 35 breaths per minute; heart rate >120 beats per minute or < 20 points from baseline; Systolic blood pressure < 90 mmHg or > 16 mmHg; Cardiac arrhythmia; Patient's request. The patients used NIV three times per day until discharge from the ICU, the arterial blood gas and chest radiograph examinations were collected as sector routine. The arterial blood samples was collected after 2 minutes in room air and chest radiograph without NIV. All postoperative patients of the ICU had NIV therapy once in the morning, once in the afternoon, once at night and only the physiotherapist applied NIV. All the patients were guided concerning how their therapy would be and, if they had queries, they were clarified before the start.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypoxia
Keywords
noninvasive ventilation, myocardial revascularization, pulmonary atelectasis, hypoxia, positive end-expiratory pressure, coronary artery bypass grafting, extracorporeal circulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
recruitment group (RG)
Arm Type
Experimental
Arm Description
After extubation the patient who was randomized to the Recruitment Group (RG) used noninvasive ventilation (NIV) associated with recruitment maneuver with PEEP 15 cm H2O and afterwards 20 cm H2O remaining 2 minutes in each, then being maintained in NIV until 30 minutes with pressure support for a tidal volume of 6 mL/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen (FiO2) for a peripheral oxygen saturation (SpO2) ≥ 95%.
Arm Title
control group (CG)
Arm Type
Active Comparator
Arm Description
After extubation the patient who was randomized to the Control Group (CG) used noninvasive ventilation (NIV) for 30 minutes with pressure support for a tidal volume of 6 ml/Kg, PEEP 8 cm H2O, FiO2 for a SpO2 ≥ 95%.
Intervention Type
Other
Intervention Name(s)
recruitment group (RG)
Intervention Description
After extubation the patient who was randomized to the Recruitment Group will use noninvasive ventilation (NIV) with alveolar recruitment maneuver with PEEP 15 cm H2O and afterwards 20 cm H2O remaining 2 minutes in each, then being maintained in NIV for 30 minutes with pressure support for a tidal volume of 6 ml/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen for a peripheral arterial Saturation of Oxygen ≥ 95%.
Intervention Type
Other
Intervention Name(s)
control group (CG)
Intervention Description
After extubation the patient who was randomized to the Control Group will use noninvasive ventilation (NIV) for 30 minutes with pressure support for a tidal volume of 6ml/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen for a peripheral arterial Saturation of Oxygen ≥ 95%.
Primary Outcome Measure Information:
Title
Oxygenation improvement
Description
Arterial blood gas sample was collected in pressure support ventilation on the day of extubation and on the following days, it was collected after 2 minutes in room air, daily until ICU discharge. Oxygenation improvement was the difference between partial oxygen pressure at the day of ICU discharge and the day of extubation.
Time Frame
from date of extubation until the date of ICU discharge, approximately one month
Secondary Outcome Measure Information:
Title
Atelectasis score improvement
Description
Radiological Atelectasis Score was attributed by a physician not related to the study, according to chest radiograph, with the following scores: 0, without atelectasis; 1, line of atelectasis or discrete infiltration; 2, partial atelectasis; 3, lobar atelectasis and 4, bilateral lobar atelectasis.
Time Frame
from date of extubation until the date of ICU discharge, approximately one month
Title
Barotrauma
Description
Occurrence of pneumothorax, pneumomediastinum, subcutaneous emphysema or pneumoperitoneum during or after noninvasive ventilation associated or not to recruitment maneuver.
Time Frame
from date of extubation until the date of ICU discharge, approximately one month
Title
Arrhythmia
Description
Occurrence of cardiac arrhythmia during or after noninvasive ventilation associated or not to recruitment maneuver.
Time Frame
from date of extubation until the date of ICU discharge, approximately one month
Title
Hemodynamic instability
Description
Occurrence of heart rate > 120 beats per minute or < 20 points from baseline value, systolic blood pressure < 90 or > 160 mmHg during or after noninvasive ventilation associated or not to recruitment maneuver.
Time Frame
from date of extubation until the date of ICU discharge, approximately one month
Title
Extubation failure rate
Description
The failure of extubation was defined as the requirement of reintubation of the extubated patients within a 48hour period.
Time Frame
from date of extubation until the date of ICU discharge, approximately one month
Title
ICU lenght of stay
Description
Number of days that the patient stayed at the ICU.
Time Frame
from date of ICU admission until the date of ICU discharge, approximately one month
Title
Mortality intrahospital
Description
Occurrence of death during hospital stay.
Time Frame
from date of hospital admission until the date of hospital discharge, approximately one month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 18 years or over; Hypoxemia defined by ratio PaO2/FiO2 < 300 in extubation; Glasgow Coma Scale > 11 after extubation; Chest radiograph with radiological atelectasis score ≥ 2 The radiological score of atelectasis: 0, without atelectasis; 1, line of atelectasis or discrete infiltration; 2, partial atelectasis; 3, lobar atelectasis and 4, bilateral lobar atelectasis. Exclusion Criteria: Use of vasoconstrictor drugs in increasing doses throughout the last two hours (norepinephrine increasing ≥ 0.5 mcg / kg / min, or increase of dopamine ≥ 5mcg/kg/min) or arterial pressure <65 mmHg; Presence of a tracheostomy; Global initiative for Obstructive Lung Disease (GOLD) classification > 2 and pulmonary fibrosis; Contraindication to use of NIV; Refuse of RM by the surgeon / doctor in charge.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carolina Fu, PhD
Organizational Affiliation
University of Sao Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital do Coracao
City
Sao Paulo
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Authors may accept to share data regarding baseline characteristics and results. Researchers with interest in the study should contact us by email to request. The request will be analyzed by the study authors.

Learn more about this trial

Efficacy and Safety of Using Noninvasive Ventilation Associated With Recruitment Maneuver in Cardiac Surgery.

We'll reach out to this number within 24 hrs